ELAN — ELANCO ANIMAL HEALTH (Healthcare >> Drug Manufacturers - Specialty & Generic)
ELAN FAQ
What is ELAN's P/E ratio?
ELANCO ANIMAL HEALTH (ELAN) currently trades at a P/E ratio of 174.66.
What is ELAN's ROE?
ELANCO ANIMAL HEALTH reports a Return on Equity (ROE) of -3.72%.
What is ELAN's dividend yield?
ELANCO ANIMAL HEALTH offers a dividend yield of 0.00%.
What is ELAN's Deepscope Quality Score?
Deepscope rates ELAN's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ELAN?
Deepscope's AI Timing Score for ELAN is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ELAN belong to?
ELANCO ANIMAL HEALTH is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NYSE exchange.
|
USD 23.63
Price
-1.08
(-4.37%)
Day Change
|
|
|---|
ELAN, the overall quality is not good ( Quality = 46) but the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is ok , ...
| Quality Factors |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 86 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 23.63 |
| PBV / Sector |
1.83 / 2.76
|
| Earning Per Share | -0.48 |
| PE / Sector |
174.66 / 23.64
|
| PEG or PE/Growth / Sector |
0.45 / 0.13
GOOD
|
| Average 1M Daily Value |
141.36 M
GREAT
|
| Average 1W Daily Value |
128.76 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
64% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:36 |
| Symbol | ELAN |
| Name | ELANCO ANIMAL HEALTH |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NYSE |
| Listed Shares | 499.45 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 11,876.91 / 9,835.56 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 450 Elanco Circle, Indianapolis, IN, United States, 46221
Phone: 877 352 6261
Website: https://www.elanco.com
Employees: 9,400
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
Google